Found: 28
Select item for more details and to access through your institution.
Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group Study.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Predictors and Outcomes of Surgery in Peritoneal Mesothelioma: an Analysis of 2000 Patients from the National Cancer Database.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 8, p. 2974, doi. 10.1245/s10434-019-08138-5
- By:
- Publication type:
- Article
A Systematic Evaluation of Multi-Gene Predictors for the Pathological Response of Breast Cancer Patients to Chemotherapy.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0049529
- By:
- Publication type:
- Article
Distinct Genes Related to Drug Response Identified in ER Positive and ER Negative Breast Cancer Cell Lines.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0040900
- By:
- Publication type:
- Article
Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer ® -Accredited Facilities in the United States.
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 1071, doi. 10.3390/cancers16051071
- By:
- Publication type:
- Article
Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study.
- Published in:
- Cancers, 2022, v. 14, n. 17, p. 4070, doi. 10.3390/cancers14174070
- By:
- Publication type:
- Article
Author Correction: Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00519-8
- By:
- Publication type:
- Article
Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine Cancer.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 4, p. e238437, doi. 10.1001/jamanetworkopen.2023.8437
- By:
- Publication type:
- Article
Cell Line Derived Multi-Gene Predictor of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer: A Validation Study on US Oncology 02-103 Clinical Trial.
- Published in:
- BMC Medical Genomics, 2012, v. 5, n. 1, p. 51, doi. 10.1186/1755-8794-5-51
- By:
- Publication type:
- Article
Prognostic Factors for High-Risk Early-Stage Epithelial Ovarian Cancer.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 10, p. 2202, doi. 10.1002/cncr.23390
- By:
- Publication type:
- Article
Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 12, p. 2786, doi. 10.1002/cncr.22351
- By:
- Publication type:
- Article
Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 9, p. 2197, doi. 10.1002/cncr.22232
- By:
- Publication type:
- Article
Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancyThe following GOG institutions participated in the current study: Duke University Medical Center (Durham, NC); Abington Memorial Hospital (Abington, PA); University of Minnesota Medical School (Minneapolis, MN); University of Mississippi Medical Center (Jackson, MS); University of California–Los Angeles (Los Angeles, CA); University of Cincinnati (Cincinnati, OH); University of North Carolina School of Medicine (Chapel Hill, NC); University of Texas/Southwestern Medical Center at Dallas (Dallas, TX); University of California–Irvine Medical Center (Orange, CA); University of Kentucky (Lexington, KY), National Cancer Institute Community Clinical Oncology Program (Bethesda, MD); Columbus Cancer Council (Columbus, OH); Medical University of South Carolina (Charleston, SC); University of Oklahoma (Oklahoma City, OK); Tacoma General Hospital
- Published in:
- Cancer (0008543X), 2004, v. 101, n. 1, p. 106
- By:
- Publication type:
- Article
Psychometric Evaluation of Two Scales Assessing Functional Status and Peripheral Neuropathy Associated With Chemotherapy for Ovarian Cancer: A Gynecologic Oncology Group Study.
- Published in:
- Oncology Nursing Forum, 2004, v. 31, n. 3, p. 615, doi. 10.1188/04.ONF.615-623
- By:
- Publication type:
- Article
Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Reclassification of serous ovarian carcinoma by a 2-tier system.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 12, p. 3087, doi. 10.1002/cncr.26618
- By:
- Publication type:
- Article
Does the Progression-Free Interval After Primary Chemotherapy Predict Survival After Salvage Chemotherapy in Advanced and Recurrent Endometrial Cancer?
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 23, p. 5407, doi. 10.1002/cncr.25480
- By:
- Publication type:
- Article
Chemotherapy intensity and toxicity among black and white women with advanced and recurrent endometrial cancer: a Gynecologic Oncology Group Study.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Chemotherapy Intensity and Toxicity Among Black and White Women With Advanced and Recurrent Endometrial Cancer.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 2, p. 355, doi. 10.1002/cncr.24769
- By:
- Publication type:
- Article
Race Does Not Impact Outcome for Advanced Ovarian Cancer Patients Treated With Cisplatin/Paclitaxel.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 18, p. 4210, doi. 10.1002/cncr.24482
- By:
- Publication type:
- Article
Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel: an analysis of Gynecologic Oncology Group trials.
- Published in:
- 2009
- By:
- Publication type:
- journal article
CA-125 Change After Chemotherapy in Prediction of Treatment Outcome Among Advanced Mucinous and Clear Cell Epithelial Ovarian Cancers: A Gynecologic Oncology Group Study.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 7, p. 1395, doi. 10.1002/cncr.24152
- By:
- Publication type:
- Article
The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma: a Gynecologic Oncology Group study.
- Published in:
- 2009
- By:
- Publication type:
- journal article
The Prognostic Value of Pretreatment CA 125 in Patients With Advanced Ovarian Carcinoma.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 5, p. 1028, doi. 10.1002/cncr.24084
- By:
- Publication type:
- Article
Racial disparities in recurrence among patients with early-stage endometrial cancer: is recurrence increased in black patients who receive estrogen replacement therapy?
- Published in:
- 2008
- By:
- Publication type:
- journal article
Uterine clear cell carcinoma risk in White versus non-White US subpopulations: does race matter?
- Published in:
- Journal of Gynecologic Oncology, 2020, v. 31, n. 6, p. 1, doi. 10.3802/jgo.2020.31.e81
- By:
- Publication type:
- Article